Yi Wang, Jin Zhou. "A prospective, single-arm phase II study of trilaciclib combined with immunotherapy and chemotherapy as first-line treatment for metastatic/recurrent esophageal squamous cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.411